Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers

Despite the progress of surgery, radiotherapy, and neoadjuvant chemotherapy, the prognosis for advanced sinonasal cancers (SNCs) remains poor. In the era of precision medicine, more research has been conducted on the molecular pathways and recurrent mutations of SNCs, with the aim of understanding c...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Andrea, Stucchi, Erika, Baronchelli, Maria, Di Mauro, Pierluigi, Ferrari, Marco, Lorini, Luigi, Gurizzan, Cristina, London, Nyall Robert Jr, Hermsen, Mario, Lechner, Matt, Bossi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698911/
https://www.ncbi.nlm.nih.gov/pubmed/36431263
http://dx.doi.org/10.3390/jcm11226787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698911/
https://www.ncbi.nlm.nih.gov/pubmed/36431263
http://dx.doi.org/10.3390/jcm11226787

Ejemplares similares